Global Intra-Aortic Balloon Pump (IABP) Market Strategic Research Report

Scope of the Report

The global Intra-Aortic Balloon Pump (IABP) market size is predicted to grow from US$ 310 million in 2025 to US$ 437 million in 2032; it is expected to grow at a CAGR of 5.1% from 2026 to 2032.

Intra-Aortic Balloon Pump, or IABP for short, is a mechanically assisted circulatory device that is currently widely used in clinical practice. A catheter with a balloon is implanted in the arterial system to the distal end of the left subclavian artery opening in the descending aorta. The filling, expansion and emptying corresponding to the cardiac cycle can cause the blood to undergo phasic changes in the aorta, thereby playing the role of mechanically assisting the circulation of a cardiac catheter treatment method. It can reduce aortic impedance, increase aortic diastolic pressure, reduce myocardial oxygen consumption, increase oxygen supply, and achieve the purpose of improving heart function.

Intra-Aortic Balloon Pump (IABP) is a medical device used to improve heart function and coronary perfusion. It is often used to treat serious heart diseases, such as heart failure, acute myocardial infarction, and support after cardiac surgery. The incidence of cardiovascular diseases in China remains high, especially with the increase in age, the number of heart disease patients increases year by year; with the continuous improvement of China's medical level, more medical institutions have begun to introduce and use IABP, especially in some tertiary hospitals and cardiology hospitals; the technological development of IABP equipment has also promoted the growth of the market; in the process of promoting medical reform, the Chinese government has strengthened its support for the treatment of major diseases, especially in the field of cardiovascular disease treatment, and the National Health Commission and local governments have continuously increased their attention to the cardiovascular field. In addition, some hospitals have received government policy and financial support when purchasing high-end medical equipment, which has also promoted the growth of the IABP market; these factors have led to a gradual increase in the demand for IABP in the Chinese market.

The Chinese market is monopolized by two brands, Getinge (Datascope) and Teleflex. Due to technical barriers and patent restrictions, no domestic company can currently produce intra-aortic balloon pumps (IABP). Therefore, all IABP products on the market come from two well-known foreign brands. This situation not only limits the independent research and development capabilities of domestic medical equipment, but also leads to the dependence of the supply of related products on the external market, which may affect the independence and innovation capabilities of my country's medical industry in key areas.

The main manufacturers in the global intra-aortic balloon pump (IABP) market include Maquet (Getinge Group), Teleflex Incorporated, Senko Medical Instrument Mfg. Co., Ltd (MERA) and other companies, and the market concentration rate is high. In 2024, the top two manufacturers in the world will account for 94% of the market share.

This report presents a comprehensive overview of the global Intra-Aortic Balloon Pump (IABP) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Fiber Optic IABP
• Ordinary IABP

Segment by Application

• Hospitals
• Cardiac Care Centers
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Intra-Aortic Balloon Pump (IABP) market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospitals, Cardiac Care Centers, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact